[
  {
    "ts": "2025-09-20T12:06:02+00:00",
    "headline": "Should You Reconsider Bristol-Myers After Shares Drop 21% Amid Pharma Tariff Uncertainty?",
    "summary": "So you are staring at Bristol-Myers Squibb's ticker and wondering if now is the time to make a move. When a stock like this shows a long-term downtrend but still dominates conversations in the pharma sector, it's only natural to ask whether the negative sentiment has gone too far. This year alone, shares have slid 20.7%, with a 6.7% decline over the last month and even a dip of 2.6% in the past week. What's driving all the caution, and is Wall Street missing something under the hood? Much of...",
    "url": "https://finance.yahoo.com/news/reconsider-bristol-myers-shares-drop-120602069.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "e10c5a4c-5027-3a04-a9bb-6d1200c0af6d",
      "content": {
        "id": "e10c5a4c-5027-3a04-a9bb-6d1200c0af6d",
        "contentType": "STORY",
        "title": "Should You Reconsider Bristol-Myers After Shares Drop 21% Amid Pharma Tariff Uncertainty?",
        "description": "",
        "summary": "So you are staring at Bristol-Myers Squibb's ticker and wondering if now is the time to make a move. When a stock like this shows a long-term downtrend but still dominates conversations in the pharma sector, it's only natural to ask whether the negative sentiment has gone too far. This year alone, shares have slid 20.7%, with a 6.7% decline over the last month and even a dip of 2.6% in the past week. What's driving all the caution, and is Wall Street missing something under the hood? Much of...",
        "pubDate": "2025-09-20T12:06:02Z",
        "displayTime": "2025-09-20T12:06:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/reconsider-bristol-myers-shares-drop-120602069.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/reconsider-bristol-myers-shares-drop-120602069.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]